Antibiotic resistance becomes a serious threat in India, ICMR report raises concerns
A recent report by the Indian Council of Medical Research has warned about the rising cases of drug-resistant infections in India. Data from 2022 to 2025 shows that 61.1% of patients were carbapenem-resistant, meaning common antibiotics are no longer effective for them. Experts believe that self-medication is making this issue increasingly fatal, putting many lives at risk.
VIMARSHNAARAD TVThe latest data released by the Indian Council of Medical Research (ICMR) highlights a significant challenge for the healthcare sector. According to the report, drug-resistant bacterial infections are spreading rapidly across India, becoming a leading cause of patient mortality. This situation becomes particularly critical when the body stops responding to standard antibiotic treatments.
The study analyzed data collected between 2022 and 2025. The findings indicate that approximately 61.1 percent of patients fall into the carbapenem-resistant category. Carbapenem is considered a potent antibiotic, but when bacteria develop resistance to it, treatment options become extremely limited.
Experts state that the indiscriminate use of antibiotics without medical supervision is the root cause of this crisis. Many individuals begin taking medications for minor ailments without consulting a doctor, which allows bacteria to develop resistance against these drugs. In medical terms, this is known as antimicrobial resistance.
When bacteria become resistant to drugs, even common infections can turn fatal. This is especially dangerous for hospitalized patients, who often have compromised immune systems. If this trend is not controlled in time, performing routine surgeries or treating minor injuries could become increasingly difficult in the future.
This ICMR report serves as a grave warning for public health. Health experts have urged the public to consume antibiotics only under the guidance of a qualified physician. Furthermore, failing to complete a prescribed course of medication helps bacteria become even more resilient.
The government and health institutions must now prioritize awareness campaigns. Strict monitoring of antibiotic sales and providing accurate information to patients are essential steps to combat this issue. This is not just a matter of individual health but is also linked to the robustness of the nation's healthcare system.
In conclusion, the issue of drug resistance is evolving into a global health crisis. Given the rising cases in India, it is clear that the time has come to exercise greater responsibility regarding the use of antibiotic medications.